- In August 2024, Biofrontera AG entered into a partnership with LEO Pharma GmbH to expand the promotion of two key dermatological products, Advantan and Skinoren, across Germany, leveraging Biofrontera’s specialized sales team to enhance treatment accessibility for conditions such as atopic dermatitis and acne vulgaris. This collaboration is expected to strengthen the market presence of both brands and support improved patient outcomes
- In June 2024, Almirall, S.A. introduced Klisyri in Europe to address actinic keratosis across larger field areas, offering patients a topical ointment with tirbanibulin that targets multiple facial and scalp lesions within a convenient five-day treatment window. This launch is set to advance Almirall’s dermatology portfolio and provide a faster, safer treatment option for patients
